Suppr超能文献

在血液透析患者中,针对氧化型心磷脂而非天然心磷脂的免疫球蛋白 (Ig)M 抗体是新型的生物标志物,与死亡率呈负相关。

Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality.

机构信息

Unit of Immunology and Chronic Disease, Division of Physiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

出版信息

Clin Exp Immunol. 2013 Dec;174(3):441-8. doi: 10.1111/cei.12181.

Abstract

The risk of premature death is high in haemodialysis (HD) patients. Antibodies against cardiolipin (anti-CL) are thrombogenic in diseases such as systemic lupus erythematosus (SLE). CL is easily oxidized (Ox) and plays a role in apoptosis. In this work we studied immunoglobulin (Ig)M anti-CL and anti-OxCL in HD-patients. We conducted an observational study with a prospective follow-up examining the relationship between anti-CL, anti-OxCL and mortality risk in a well-characterized cohort of 221 prevalent HD patients [56% men, median age 66 (interquartile range 51-74) years, vintage time 29 (15-58) months] with a mean follow-up period of 41 (20-48 months). According to the receiver operator characteristic (ROC) analysis, anti-OxCL [area under the curve (AUC) 0·62, P < 0·01], but not anti-CL (AUC 0·52, P = 0·2), is associated with mortality. In crude and adjusted Cox analysis, every log increase in anti-OxCL inversely predicted all-cause [adjusted hazard ratios (HR) 0·62 (0·43-0·89)] and CVD-related [adjusted HR 0·56 (0·32-0·98)] mortality. Patients with anti-OxCL levels below median also had increased all-cause and cardiovascular disease (CVD)-related mortality. Although anti-OxCL and anti-phosphorylcholine (PC) were related positively to each other (ρ = 0·57, P < 0·01), patients with one or two of these autoantibody levels below the median were associated with an incrementally increased death risk. Anti-OxCL were co-factor β2-GPI-independent; anti-CL from patients with anti-phospholipid antibody syndrome were β2-GPI-dependent, while sera from HD-patients less so. Sera from healthy donors was not β2-GPI-dependent. Anti-OxCL IgM is β2-glycoprotein 1 (GPI)-independent and a novel biomarker; low levels are associated with death among HD patients (and high levels with decreased risk). Combination with anti-PC increases this association. Putative therapeutic implications warrant further investigation.

摘要

在血液透析(HD)患者中,过早死亡的风险很高。抗心磷脂(anti-CL)抗体在红斑狼疮(SLE)等疾病中具有血栓形成作用。CL 很容易被氧化(Ox),并在细胞凋亡中发挥作用。在这项工作中,我们研究了 HD 患者中的 IgM 抗-CL 和抗-OxCL。我们进行了一项观察性研究,前瞻性随访了 221 例典型 HD 患者(56%为男性,中位年龄 66(51-74)岁,治疗时间 29(15-58)个月),平均随访时间为 41(20-48)个月),研究了抗-CL、抗-OxCL 与死亡率之间的关系。根据接收者操作特征(ROC)分析,抗-OxCL[曲线下面积(AUC)0·62,P<0·01],而不是抗-CL(AUC 0·52,P=0·2)与死亡率相关。在未经调整和调整后的 Cox 分析中,抗-OxCL 每增加一个对数,全因死亡的风险就会降低[调整后的危害比(HR)0·62(0·43-0·89)]和心血管疾病(CVD)相关死亡的风险[调整后的 HR 0·56(0·32-0·98)]。抗-OxCL 水平低于中位数的患者也有更高的全因死亡和心血管疾病(CVD)相关死亡风险。尽管抗-OxCL 和抗磷酰胆碱(PC)之间存在正相关(ρ=0·57,P<0·01),但这些自身抗体中有一种或两种水平低于中位数的患者,其死亡风险会逐渐增加。抗-OxCL 与β2-糖蛋白 I 无关;抗磷脂抗体综合征患者的抗-CL 依赖于β2-糖蛋白 I,而 HD 患者的抗-CL 则不然。健康供体的血清不依赖于β2-糖蛋白 I。抗-OxCL IgM 与β2-糖蛋白 1(GPI)无关,是一种新的生物标志物;低水平与 HD 患者的死亡相关(高水平与风险降低相关)。与抗-PC 结合可增加这种关联。进一步的治疗意义值得进一步研究。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验